145 related articles for article (PubMed ID: 37494056)
21. Treatment of relapse and survival outcomes after liver transplantation in patients with colorectal liver metastases.
Dueland S; Smedman TM; Røsok B; Grut H; Syversveen T; Jørgensen LH; Line PD
Transpl Int; 2021 Nov; 34(11):2205-2213. PubMed ID: 34792825
[TBL] [Abstract][Full Text] [Related]
22. Prognostic indicators lose their value with repeated resection of colorectal liver metastases.
Schmidt T; Nienhüser H; Kuna C; Klose J; Strowitzki MJ; Büchler MW; Ulrich A; Schneider M
Eur J Surg Oncol; 2018 Oct; 44(10):1610-1618. PubMed ID: 30115500
[TBL] [Abstract][Full Text] [Related]
23. Solitary colorectal liver metastasis after curative intent surgery: prognostic factors affecting outcomes and survival.
Shin H; Kim CW; Lee JL; Yoon YS; Park IJ; Lim SB; Yu CS; Kim JC
ANZ J Surg; 2019 Jan; 89(1-2):61-67. PubMed ID: 30484933
[TBL] [Abstract][Full Text] [Related]
24. Effect of Time to Surgery of Colorectal Liver Metastases on Survival.
Chen EY; Mayo SC; Sutton T; Kearney MR; Kardosh A; Vaccaro GM; Billingsley KG; Lopez CD
J Gastrointest Cancer; 2021 Mar; 52(1):169-176. PubMed ID: 32086781
[TBL] [Abstract][Full Text] [Related]
25. [Prognostic factors of patients with unresectable liver metastasis from colorectal cancer after failed conversion chemotherapy].
He H; Shen W; Chen W; Liu H; Gong W; Fu J; Hu X; Cui L
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Nov; 21(11):1261-1267. PubMed ID: 30506537
[TBL] [Abstract][Full Text] [Related]
26. Resection of Colorectal Liver Metastasis: Prognostic Impact of Tumor Burden vs KRAS Mutational Status.
Tsilimigras DI; Hyer JM; Bagante F; Guglielmi A; Ruzzenente A; Alexandrescu S; Poultsides G; Sasaki K; Aucejo F; Pawlik TM
J Am Coll Surg; 2021 Apr; 232(4):590-598. PubMed ID: 33383214
[TBL] [Abstract][Full Text] [Related]
27. Effect of Liver Transplant on Long-term Disease-Free Survival in Children With Hepatoblastoma and Hepatocellular Cancer.
Pham TA; Gallo AM; Concepcion W; Esquivel CO; Bonham CA
JAMA Surg; 2015 Dec; 150(12):1150-8. PubMed ID: 26308249
[TBL] [Abstract][Full Text] [Related]
28. Treatment of pulmonary colorectal metastases by radiofrequency ablation.
Petre EN; Jia X; Thornton RH; Sofocleous CT; Alago W; Kemeny NE; Solomon SB
Clin Colorectal Cancer; 2013 Mar; 12(1):37-44. PubMed ID: 23026111
[TBL] [Abstract][Full Text] [Related]
29. Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer.
Margonis GA; Buettner S; Andreatos N; Kim Y; Wagner D; Sasaki K; Beer A; Schwarz C; Løes IM; Smolle M; Kamphues C; He J; Pawlik TM; Kaczirek K; Poultsides G; Lønning PE; Cameron JL; Burkhart RA; Gerger A; Aucejo FN; Kreis ME; Wolfgang CL; Weiss MJ
JAMA Surg; 2018 Jul; 153(7):e180996. PubMed ID: 29799910
[TBL] [Abstract][Full Text] [Related]
30. Primary tumor location affects recurrence-free survival for patients with colorectal liver metastases after hepatectomy: a propensity score matching analysis.
Zhang Y; Wang Y; Yuan Y; Qiu J; Qiu Y; He W; Zheng Y; Wang Z; Gu Y; Lu Z; Chen G; Ding P; Wu X; Pan Z; Wan D; Li Y; Xu R; Yuan Y; Li B
World J Surg Oncol; 2020 May; 18(1):98. PubMed ID: 32423450
[TBL] [Abstract][Full Text] [Related]
31. Chemotherapy or liver transplantation for nonresectable liver metastases from colorectal cancer?
Dueland S; Guren TK; Hagness M; Glimelius B; Line PD; Pfeiffer P; Foss A; Tveit KM
Ann Surg; 2015 May; 261(5):956-60. PubMed ID: 24950280
[TBL] [Abstract][Full Text] [Related]
32. Clinical features and prognosis in hepatectomy for colorectal cancer with centrally located liver metastasis.
Kuo IM; Huang SF; Chiang JM; Yeh CY; Chan KM; Chen JS; Yu MC
World J Surg Oncol; 2015 Mar; 13():92. PubMed ID: 25889950
[TBL] [Abstract][Full Text] [Related]
33. Effect of tumour size ratio on liver recurrence-free survival of patients undergoing hepatic resection for colorectal liver metastases.
Zhai Y; Bai W; Zhou J; Dong Q; Zhang J
BMC Cancer; 2022 Jan; 22(1):103. PubMed ID: 35078439
[TBL] [Abstract][Full Text] [Related]
34. Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases.
Swierz MJ; Storman D; Riemsma RP; Wolff R; Mitus JW; Pedziwiatr M; Kleijnen J; Bala MM
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009498. PubMed ID: 32163181
[TBL] [Abstract][Full Text] [Related]
35. Risk factors for survival following recurrence after first liver resection for colorectal cancer liver metastases.
Serrano PE; Gu CS; Husien M; Jalink D; Ritter A; Martel G; Tsang ME; Law CH; Hallet J; McAlister V; Sela N; Solomon H; Moulton CA; Gallinger S; Levine M
J Surg Oncol; 2019 Dec; 120(8):1420-1426. PubMed ID: 31612509
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of Definitive Stereotactic Body Radiotherapy and Outcomes in Adults With Extracranial Oligometastasis.
Poon I; Erler D; Dagan R; Redmond KJ; Foote M; Badellino S; Biswas T; Louie AV; Lee Y; Atenafu EG; Ricardi U; Sahgal A
JAMA Netw Open; 2020 Nov; 3(11):e2026312. PubMed ID: 33196810
[TBL] [Abstract][Full Text] [Related]
37. Liver transplantation in a patient with unresectable colorectal liver metastases -- a case report.
Hrehoreţ D; Alexandrescu S; Braşoveanu V; Grigorie R; Zielinski C; Popescu I
Chirurgia (Bucur); 2013; 108(5):719-24. PubMed ID: 24157119
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of metabolic parameters in patients with synchronous colorectal cancer liver metastasis following curative-intent colorectal and hepatic surgery.
Lee HS; Kim HO; Hong YS; Kim TW; Kim JC; Yu CS; Kim JS
J Nucl Med; 2014 Apr; 55(4):582-9. PubMed ID: 24549284
[TBL] [Abstract][Full Text] [Related]
39. Effect of PET-CT on disease recurrence and management in patients with potentially resectable colorectal cancer liver metastases. Long-term results of a randomized controlled trial.
Serrano PE; Gu CS; Moulton CA; Husien M; Jalink D; Martel G; Tsang ME; Hallet J; McAlister V; Gallinger S; Levine M
J Surg Oncol; 2020 May; 121(6):1001-1006. PubMed ID: 32034769
[TBL] [Abstract][Full Text] [Related]
40. Additional chemotherapy improved local control and overall survival after stereotactic body radiation therapy for patients with oligo-recurrence.
Nakamura M; Hashimoto N; Mayahara H; Uezono H; Harada A; Nishikawa R; Matsuo Y; Kawaguchi H; Nishimura H
Radiat Oncol; 2018 Apr; 13(1):75. PubMed ID: 29688858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
